Melipramin (Imipramine Hydrochloride)

Imipramine inhibits the reuptake of norepinephrine and serotonin at neuronal synapses, increasing their levels in the brain. This enhances neurotransmission in circuits that regulate mood and anxiety, while also affecting pathways involved in bladder function.

The appropriate dose of Melipramin is individualized by the prescribing clinician based on the specific indication, patient age, weight, clinical response, and tolerability. Dosage adjustments are made according to therapeutic goals and any observed side effects.

Safety data for imipramine in pregnancy and lactation are limited. Clinicians weigh potential benefits against possible risks, and the drug should only be used if clearly needed. Breastfeeding mothers should consult their healthcare provider before use.

To request Melipramin, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details, and any necessary import documentation.

Melipramin belongs to the tricyclic antidepressant class, which generally has a broader receptor profile than selective serotonin reuptake inhibitors (SSRIs). While both improve mood, tricyclics may have more anticholinergic and cardiovascular effects, whereas SSRIs tend to have a more favorable side‑effect profile for many patients.

Melipramin should be stored at ambient temperature, preferably below 25 °C. Keep the product in its original packaging, protect it from moisture, and store it out of direct sunlight to maintain stability.

Melipramin is taken orally, usually with a glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal discomfort. Patients should follow the prescribing clinician’s instructions regarding timing and any dose adjustments.

Serious risks include cardiac arrhythmias, especially in patients with pre‑existing heart disease, severe hypotension, seizures, and the potential for worsening depression or suicidal thoughts. Prompt medical attention is required if any of these events occur.

Melipramin should be avoided in individuals who have recently used monoamine oxidase inhibitors, have a known hypersensitivity to tricyclic antidepressants, have recent myocardial infarction, severe conduction disorders, or uncontrolled narrow‑angle glaucoma. Clinicians must assess each patient’s medical history before initiating therapy.